Zhejiang Zhenyuan Share Co Ltd

SHE:000705 China Drug Manufacturers - General
Market Cap
$413.03 Million
CN¥3.03 Billion CNY
Market Cap Rank
#12711 Global
#3191 in China
Share Price
CN¥9.07
Change (1 day)
-1.09%
52-Week Range
CN¥7.38 - CN¥10.55
All Time High
CN¥18.44
Categories
Companies in China Drug Manufacturers - General
About

Zhejiang Zhenyuan Share Co.,Ltd. engages in the manufacture and wholesale of pharmaceutical products in China and internationally. Its products include Chinese herbal medicines and slices, Chinese patent medicines, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provide… Read more

Zhejiang Zhenyuan Share Co Ltd (000705) - Net Assets

Latest net assets as of September 2025: CN¥2.02 Billion CNY

Based on the latest financial reports, Zhejiang Zhenyuan Share Co Ltd (000705) has net assets worth CN¥2.02 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.03 Billion) and total liabilities (CN¥1.01 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥2.02 Billion
% of Total Assets 66.57%
Annual Growth Rate 13.94%
5-Year Change 11.34%
10-Year Change 53.43%
Growth Volatility 68.35

Zhejiang Zhenyuan Share Co Ltd - Net Assets Trend (1993–2024)

This chart illustrates how Zhejiang Zhenyuan Share Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Zhejiang Zhenyuan Share Co Ltd (1993–2024)

The table below shows the annual net assets of Zhejiang Zhenyuan Share Co Ltd from 1993 to 2024.

Year Net Assets Change
2024-12-31 CN¥1.96 Billion -1.85%
2023-12-31 CN¥2.00 Billion +2.72%
2022-12-31 CN¥1.95 Billion +3.95%
2021-12-31 CN¥1.87 Billion +6.24%
2020-12-31 CN¥1.76 Billion +2.93%
2019-12-31 CN¥1.71 Billion +18.60%
2018-12-31 CN¥1.44 Billion +3.87%
2017-12-31 CN¥1.39 Billion +5.76%
2016-12-31 CN¥1.31 Billion +2.75%
2015-12-31 CN¥1.28 Billion +4.59%
2014-12-31 CN¥1.22 Billion +3.79%
2013-12-31 CN¥1.18 Billion +6.09%
2012-12-31 CN¥1.11 Billion +102.59%
2011-12-31 CN¥548.02 Million -0.08%
2010-12-31 CN¥548.48 Million +3.95%
2009-12-31 CN¥527.66 Million +3.43%
2008-12-31 CN¥510.16 Million +0.92%
2007-12-31 CN¥505.50 Million +4.07%
2006-12-31 CN¥485.74 Million +1.11%
2005-12-31 CN¥480.42 Million +1.42%
2004-12-31 CN¥473.67 Million +2.02%
2003-12-31 CN¥464.31 Million +4.82%
2002-12-31 CN¥442.98 Million +3.67%
2001-12-31 CN¥427.30 Million -2.73%
2000-12-31 CN¥439.28 Million +56.55%
1999-12-31 CN¥280.61 Million +5.87%
1998-12-31 CN¥265.05 Million +6.35%
1997-12-31 CN¥249.22 Million +379.91%
1996-12-31 CN¥51.93 Million +10.76%
1995-12-31 CN¥46.89 Million +7.02%
1994-12-31 CN¥43.81 Million +27.56%
1993-12-31 CN¥34.35 Million --

Equity Component Analysis

This analysis shows how different components contribute to Zhejiang Zhenyuan Share Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 94307291900.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥943.07 Million 48.10%
Common Stock CN¥334.12 Million 17.04%
Other Components CN¥683.40 Million 34.86%
Total Equity CN¥1.96 Billion 100.00%

Zhejiang Zhenyuan Share Co Ltd Competitors by Market Cap

The table below lists competitors of Zhejiang Zhenyuan Share Co Ltd ranked by their market capitalization.

Company Market Cap
Lindex Group
HE:LINDEX
 		$307.12 Million
Zhejiang Shouxiangu Pharm Co
SHG:603896
 		$307.16 Million
DONGGUAN R.COMMERC. H YC1
F:857
 		$307.20 Million
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
 		$307.28 Million
Facc AG
VI:FACC
 		$307.05 Million
Alpargatas S.A
SA:ALPA3
 		$307.02 Million
Garware Hi-Tech Films Limited
NSE:GRWRHITECH
 		$306.95 Million
Cedar Woods Properties Ltd
AU:CWP
 		$306.94 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhejiang Zhenyuan Share Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,975,931,610 to 1,960,598,883, a change of -15,332,727 (-0.8%).
  • Net income of 34,729,260 contributed positively to equity growth.
  • Dividend payments of 23,905,346 reduced retained earnings.
  • Other factors decreased equity by 26,156,641.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥34.73 Million +1.77%
Dividends Paid CN¥23.91 Million -1.22%
Other Changes CN¥-26.16 Million -1.33%
Total Change CN¥- -0.78%

Book Value vs Market Value Analysis

This analysis compares Zhejiang Zhenyuan Share Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.61x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 66.17x to 1.61x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1993-12-31 CN¥0.14 CN¥9.07 x
1994-12-31 CN¥0.17 CN¥9.07 x
1995-12-31 CN¥0.19 CN¥9.07 x
1996-12-31 CN¥0.21 CN¥9.07 x
1997-12-31 CN¥0.72 CN¥9.07 x
1998-12-31 CN¥0.75 CN¥9.07 x
1999-12-31 CN¥0.80 CN¥9.07 x
2000-12-31 CN¥1.64 CN¥9.07 x
2001-12-31 CN¥1.65 CN¥9.07 x
2002-12-31 CN¥1.71 CN¥9.07 x
2003-12-31 CN¥1.77 CN¥9.07 x
2004-12-31 CN¥1.80 CN¥9.07 x
2005-12-31 CN¥1.82 CN¥9.07 x
2006-12-31 CN¥1.84 CN¥9.07 x
2007-12-31 CN¥1.92 CN¥9.07 x
2008-12-31 CN¥1.93 CN¥9.07 x
2009-12-31 CN¥2.00 CN¥9.07 x
2010-12-31 CN¥2.10 CN¥9.07 x
2011-12-31 CN¥2.14 CN¥9.07 x
2012-12-31 CN¥4.17 CN¥9.07 x
2013-12-31 CN¥3.45 CN¥9.07 x
2014-12-31 CN¥3.72 CN¥9.07 x
2015-12-31 CN¥3.77 CN¥9.07 x
2016-12-31 CN¥4.00 CN¥9.07 x
2017-12-31 CN¥4.03 CN¥9.07 x
2018-12-31 CN¥4.22 CN¥9.07 x
2019-12-31 CN¥5.06 CN¥9.07 x
2020-12-31 CN¥5.21 CN¥9.07 x
2021-12-31 CN¥5.55 CN¥9.07 x
2022-12-31 CN¥5.75 CN¥9.07 x
2023-12-31 CN¥5.91 CN¥9.07 x
2024-12-31 CN¥5.65 CN¥9.07 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhejiang Zhenyuan Share Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.77%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.93%
  • • Asset Turnover: 1.09x
  • • Equity Multiplier: 1.74x
  • Recent ROE (1.77%) is below the historical average (6.57%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1993 19.93% 4.12% 1.35x 3.59x CN¥3.41 Million
1994 17.25% 4.53% 1.23x 3.09x CN¥3.17 Million
1995 19.78% 4.28% 1.40x 3.31x CN¥4.59 Million
1996 19.23% 3.78% 1.53x 3.33x CN¥4.79 Million
1997 13.12% 7.42% 0.57x 3.09x CN¥5.65 Million
1998 11.52% 5.44% 0.72x 2.94x CN¥2.85 Million
1999 10.75% 4.49% 0.86x 2.77x CN¥1.51 Million
2000 5.09% 4.12% 0.71x 1.74x CN¥-20.23 Million
2001 4.14% 3.43% 0.75x 1.61x CN¥-24.24 Million
2002 3.31% 2.48% 0.78x 1.71x CN¥-28.65 Million
2003 3.43% 2.37% 0.82x 1.75x CN¥-29.17 Million
2004 1.60% 1.01% 0.91x 1.74x CN¥-37.84 Million
2005 1.16% 0.60% 1.06x 1.83x CN¥-40.29 Million
2006 1.68% 0.85% 1.06x 1.86x CN¥-38.41 Million
2007 1.61% 0.81% 1.08x 1.84x CN¥-40.32 Million
2008 2.53% 1.10% 1.24x 1.85x CN¥-36.15 Million
2009 3.55% 1.39% 1.34x 1.90x CN¥-32.27 Million
2010 4.05% 1.40% 1.36x 2.12x CN¥-30.95 Million
2011 5.84% 1.83% 1.41x 2.26x CN¥-22.47 Million
2012 4.32% 2.63% 1.10x 1.50x CN¥-62.65 Million
2013 5.51% 3.19% 1.16x 1.49x CN¥-52.42 Million
2014 3.23% 1.88% 1.15x 1.49x CN¥-82.08 Million
2015 2.86% 1.67% 1.12x 1.53x CN¥-90.31 Million
2016 3.50% 1.86% 1.21x 1.56x CN¥-84.06 Million
2017 4.46% 2.37% 1.26x 1.50x CN¥-75.81 Million
2018 4.98% 2.48% 1.35x 1.49x CN¥-71.40 Million
2019 12.52% 6.52% 1.25x 1.53x CN¥42.57 Million
2020 5.13% 2.60% 1.27x 1.55x CN¥-84.75 Million
2021 4.17% 2.14% 1.21x 1.61x CN¥-108.07 Million
2022 4.05% 1.88% 1.28x 1.68x CN¥-114.34 Million
2023 4.13% 1.99% 1.40x 1.49x CN¥-115.95 Million
2024 1.77% 0.93% 1.09x 1.74x CN¥-161.33 Million

Industry Comparison

This section compares Zhejiang Zhenyuan Share Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

  • Industry: Drug Manufacturers - General
  • Average net assets among peers: $828,109,057
  • Average return on equity (ROE) among peers: 7.93%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Zhejiang Zhenyuan Share Co Ltd (000705) CN¥2.02 Billion 19.93% 0.50x $307.06 Million
Zhejiang Int'L Group Co Ltd (000411) $189.44 Million 3.08% 4.33x $199.04 Million
Hunan Jingfeng Pharmaceutical (000908) $336.40 Million 0.81% 1.44x $202.85 Million
Hubei Guangji Pharmaceutical Co Ltd (000952) $1.49 Billion 3.37% 0.66x $229.65 Million
Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367) $1.25 Billion 8.38% 0.07x $144.69 Million
Yifan Xinfu Pharmaceutical Co Ltd (002019) $507.64 Million 23.17% 1.09x $1.01 Billion
Guangdong Jiaying Pharmaceutical Co Ltd (002198) $226.35 Million 6.06% 0.04x $447.60 Million
Chongqing Lummy Pharmaceutical (300006) $1.88 Billion -4.66% 0.52x $475.43 Million
Zhejiang Jolly Pharmaceutical Co Ltd (300181) $1.39 Billion 1.50% 0.52x $1.19 Billion
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) $181.38 Million 29.65% 0.05x $893.83 Million